The technical reference,
verified to the lot.
Mechanism of action, reconstitution and stability, and how to read a Certificate of Analysis. Rigorous, research-use-only explainers — where every claim about a compound is one you can verify by lot number.
Mechanism of action, receptor targets, and molecular profiles for each research compound.
How co-formulated research compounds are studied together — complementary mechanisms and handling.
Reconstitution, storage, and stability — for laboratory settings, not human use.
How to read a Certificate of Analysis and verify identity and purity to the lot.
Mechanism and receptor-target comparisons between related compounds.
A section-by-section guide to reading a peptide COA: HPLC chromatograms, mass-spec identity, net peptide content, counterion, and lot traceability.
Laboratory guidance on reconstituting lyophilized research peptides: choosing a diluent, gentle technique to avoid degradation, and concentration considerations. RUO.
Retatrutide (LY3437943) is a synthetic triple incretin receptor agonist targeting GIP, GLP-1, and glucagon receptors. Mechanism and molecular data. RUO.
Tirzepatide is a synthetic dual GIP/GLP-1 incretin receptor agonist. Receptor targets, mechanism, molecular design, and accurate molecular data. Research use only.
BPC-157 is a synthetic 15-amino-acid partial sequence of body protection compound. Angiogenesis and tissue-repair pathways studied in models, plus molecular data. RUO.
A target-by-target mechanism comparison of tirzepatide (dual GIP/GLP-1 agonist) and retatrutide (triple GIP/GLP-1/glucagon agonist) for research reference.